Identification of intrinsic subtype-specific prognostic microRNAs in primary glioblastoma

BackgroundGlioblastoma multiforme (GBM) is the most malignant type of glioma. Integrated classification based on mRNA expression microarrays and whole–genome methylation subdivides GBM into five subtypes: Classical, Mesenchymal, Neural, Proneural-CpG island methylator phenotype (G-CIMP) and Proneural-non G-CIMP. Biomarkers that can be used to predict prognosis in each subtype have not been systematically investigated.MethodsIn the present study, we used Cox regression and risk-score analysis to construct respective prognostic microRNA (miRNA) signatures in the five intrinsic subtypes of primary glioblastoma in The Cancer Genome Atlas (TCGA) dataset.ResultsPatients who had high-risk scores had poor overall survival compared with patients who had low-risk scores. The prognostic miRNA signature for the Mesenchymal subtype (four risky miRNAs: miR-373, miR-296, miR-191, miR-602; one protective miRNA: miR-223) was further validated in an independent cohort containing 41 samples.ConclusionWe report novel diagnostic tools for deeper prognostic sub-stratification in GBM intrinsic subtypes based upon miRNA expression profiles and believe that such signature could lead to more individualized therapies to improve survival rates and provide a potential platform for future studies on gene treatment for GBM.

[1]  Yingdong Zhao,et al.  Analysis of Gene Expression Data Using BRB-Array Tools , 2007, Cancer informatics.

[2]  L. Staudt,et al.  Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. , 2004, The New England journal of medicine.

[3]  Paola Pisani,et al.  Genetic Pathways to Glioblastoma , 2004, Cancer Research.

[4]  P. Kleihues,et al.  Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. , 2005, Journal of neuropathology and experimental neurology.

[5]  Thomas D. Wu,et al.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.

[6]  F. Ducray,et al.  Predictive and prognostic factors for gliomas , 2011, Expert review of anticancer therapy.

[7]  Keith Paulsen,et al.  Genetics of glioblastoma: a window into its imaging and histopathologic variability. , 2011, Radiographics : a review publication of the Radiological Society of North America, Inc.

[8]  G. Fuller,et al.  Moving toward molecular classification of diffuse gliomas in adults , 2012, Neurology.

[9]  T. Jiang,et al.  Oncogene addiction in gliomas: Implications for molecular targeted therapy , 2011, Journal of experimental & clinical cancer research : CR.

[10]  F. Ducray,et al.  IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.

[11]  R. McLendon,et al.  IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.

[12]  Jianguo Sun,et al.  Cox Survival Analysis of Microarray Gene Expression Data Using Correlation Principal Component Regression , 2007, Statistical applications in genetics and molecular biology.

[13]  Ya-ping Zhang,et al.  Mitochondrial diversity and phylogeographic structure of Chinese domestic goats. , 2005, Molecular phylogenetics and evolution.

[14]  L. Deangelis,et al.  Glioblastoma and other malignant gliomas: a clinical review. , 2013, JAMA.

[15]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[16]  M. Gilbert,et al.  Chapter 32 - Glioblastoma , 2012 .

[17]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[18]  K. Somasundaram,et al.  Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma , 2010, Modern Pathology.

[19]  T. Jiang,et al.  Genome-wide DNA methylation profiling identifies ALDH1A3 promoter methylation as a prognostic predictor in G-CIMP- primary glioblastoma. , 2013, Cancer letters.

[20]  Lei Han,et al.  Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group. , 2012, Neuro-oncology.

[21]  Yuri Kotliarov,et al.  Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. , 2009, Cancer research.

[22]  Jun Z. Li,et al.  Genomic Estimates of Aneuploid Content in Glioblastoma Multiforme and Improved Classification , 2012, Clinical Cancer Research.

[23]  Yuan Qi,et al.  Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA , IDH 1 , EGFR , and NF 1 Citation Verhaak , 2010 .

[24]  D. Haussler,et al.  The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.

[25]  T. Jiang,et al.  Whole‐genome microRNA expression profiling identifies a 5‐microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme , 2013, Cancer.

[26]  R. Wilson,et al.  Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.